Ligand binding to oligonucleotides.
Department of Pharmaceutical Chemistry, University of Jordan, Amman, Jordan.
I I
II
Hamdan
G G
GG
Skellern
R D
RD
Waigh
D000998:Antiviral Agents / Q000737:chemistry / Q000378:metabolism; D006690:Bisbenzimidazole / Q000737:chemistry / Q000378:metabolism; D004247:DNA / Q000032:analysis / Q000378:metabolism*; D003609:Dactinomycin / Q000737:chemistry / Q000378:metabolism; D004214:Distamycins / Q000737:chemistry / Q000378:metabolism; D019075:Electrophoresis, Capillary / Q000379:methods*; D004996:Ethidium / Q000737:chemistry / Q000378:metabolism; D005456:Fluorescent Dyes / Q000737:chemistry / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007364:Intercalating Agents / Q000737:chemistry / Q000378:metabolism; D008024:Ligands; D015394:Molecular Structure; D009429:Netropsin / Q000737:chemistry / Q000378:metabolism; D019384:Nucleic Acid Synthesis Inhibitors / Q000737:chemistry / Q000378:metabolism; D009841:Oligonucleotides / Q000737:chemistry / Q000378:metabolism*
D000998:Antiviral Agents; D004214:Distamycins; D005456:Fluorescent Dyes; D007364:Intercalating Agents; D008024:Ligands; D019384:Nucleic Acid Synthesis Inhibitors; D009841:Oligonucleotides; D003609:Dactinomycin; D009429:Netropsin; C030000:stallimycin; D004247:DNA; D004996:Ethidium; D006690:Bisbenzimidazole